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1. Introduction 
25-Hydroxylation of vitamin D3 has been shown 
catalyzed both by the microsomal [ 1,2] and the 
mitochondrial [3] fraction of rat liver. As yet, only 
the mitochondrial activity has been assayed under 
enzymological conditions involving substrate satu- 
ration [3], At present no definitive conclusions can 
be drawn concerning the relative physiologicai 
importance of these two hydroxylases. Both enzymes 
seem to be mixed function oxidases since the oxygen 
incorporated in the 25position is derived from 
molecular oxygen both when the mitochondrial [3] 
and the microsomal fraction [4] is used. In contrast 
to the mitochondrial activity [3], the microsomal 
activity seems to be affected by the vitamin D status 
of the animal [l]. Whether this is due to the 
hydroxylase per se or some other factor is unknown, 
however. 
In a study on the mitochondri~ vitamin Ds 
25hydroxylase, it was shown that this enzyme had 
properties similar to a cytochrome P-450 mono- 
oxygenase [3]. Thus the enzyme required NADPH, 
wasinhibited by CO, and was stimulated by treatment 
with phenobarbital in vivo. 
Recently, cytochrome P-450 was solubilized from 
rat liver mitochondria [5-71. It is shown in the 
present work that this cytochrome P-450 preparation 
in the presence of NADPH, ferredoxin and ferredoxin 
reductase catalyzes the conversion of vitamin Da 
into a more polar product identified as 25hydroxy- 
vitamin D3 by gas chromatograplly-rn~s 
spectrometry (%-MS). 
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2. Materials and methods 
Male Wistar rats were fed an ordinary pellet diet. 
A group of 5 animals (-200 g) was given pheno- 
barbital (1 g/l) in the drinking water for 30 days 
before sacrifice. This treatment has been shown to 
markedly increase the content of cytochrome P-450 
in the liver mitochondria [8] and to stimulate the 
mit~hondri~ vitamin Da 25hydroxylase activity 
131. 
The procedures for preparing liver mitochondria 
[9], liver mitochondrial cytochrome P-450 [S], 
adrenal ferredoxin [ 101 and adrenal ferredoxin 
reductase [9] have been reported [9]. The specific 
content of liver mitochondrial cytochrome P-450 
was 0.4 nmol/mg protein. The adrenal ferredoxin 
exhibited an A414/A280 of 0.71 and the ferredoxin 
reductase&e/A,, of 0.128. Both proteins were 
homogenous on SDS-polyacrylamide gel 
electrophoresis. 
Vitamin Ds (cholecal~iferol) from Sigma 
Chemical Co. (St Louis, MO) was purified on high- 
pressure liquid chromatography (HPLC) on a silicic 
acid column (see below). 25-Hydroxyvitamin Da 
was a generous gift of Professor H. F, DeLuca, 
University of Wisconsin, Madison. 25-Hydroxy- 
[26-‘Hs]vitamin Da was synthesized as in [ 1 I]. All 
other chemicals and biochemicals were standard 
commercial high purity materials. 
Vitamin Da 25-hydroxylase activity was assayed 
in a medium that contained the following in 1.5 ml 
35 mM MOPS buffer (pH 7.7): 1 pmol glucose-6- 
phosphate, 0.5 unit glucose-6-pl~osphate d hydro- 
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genase, 1 pmol MgClz and 0.1 pmol NADP. The 
amounts of enzymes are given in table 1. The reaction 
was started by the addition of 150 pg vitamin Da in 
25 fl ethanol and allowed to continue for 60 min at 
37°C under oxygen. The reaction was terminated by 
the addition of 10 ml methanol:chloroform (2: 1) 
together with 145 ng *Ha-labelled 25-hydroxyvitamin 
Ds. After extraction [5] the chloroform was 
evaporated under N2 and the residue redissolved in 
100 ~1 eluting solvent used for HPLC. The total 
sample was injected into a Spectra Physics HPLC 
instrument fitted with a Rheodyne injector, an 
ultraviolet detector and a Spherisorb 5 nm ODS 
column (4.6 X 250 mm). The sample was eluted with 
5% Hz0 in methanol at 0.8 ml/min flow rate. The 
fraction corresponding to eluted 25-hydroxyvitamin 
D3 was collected. The solvent was evaporated under 
N, and after redissolving in 100 ~1 of the next eluting 
solvent the sample was rechromatographed on a 
Spherisorb 5 ym silica column (3 X 250 mm). The 
sample was eluted with 7.5% isopropanol in hexane at 
0.8 ml/min flow rate. The fraction corresponding to 
25-hydroxyvitamin Ds was collected in 0.8 ml, the 
solvent was removed and the trimethylsilyl/t-butyl- 
dimethylsilyl derivative formed as in [3]. The 
derivative of the extract was then dissolved in 
20-50 1.11 hexane and aliquots were analysed by 
G-MS using an LKB 209 1 instrument equipped 
with a multiple ion detector (MID) essentially as in 
[3 1. The first channel of the multiple ion detector 
was focused on the ion at m/e 586 and the second 
at the ion m/e 589. The ratio between peaks at mfe 
586 and mfe 589 was compared to a standard curve 
]31* 
In order to identify the reaction product purified 
material from 3 incubations without added *Ha- 
labelled 25-hydroxyvitamin Ds was combined and 
analyzed by CC-MS. 
3. Results 
Reversed-phase HPLC on Spherisorb ODS of the 
chloroform extract of the complete incubation 
mixture (with no *Ha-labelled 25-hydroxyvitamin Da 
added) revealed that vitamin Ds had been transformed 
into more polar products. Rechromatography on 
Spherisorb silica of the fraction with retention time 
corresponding to 25-hydroxyvitamin Ds disclosed that 
one of these products had a retention time identical 
to 25-hydroxyvitamin Ds also in this system 
(fig.1 A,B). In the absence of ferredoxin in the 
incubation medium, the corresponding peak was not 
detectable (fig.1 C). 
Exact determination of the amount of product 
formed was made after addition of *Hs labelled 
25-hydroxyvitamin Ds to the incubation mixture 
prior to extraction and chromatography as above. In 
fig.2A, MID-recordings at m/e 586 and mje 589 are 
shown of the derivative of a purified extract of the 
complete incubation mixture. In consonance with 
the work in [3], two peaks were obtained, corre- 
sponding to the pyro- and isopyro-form of the 
derivative of vitamin Ds. Peaks were obtained in the 
tracing at m/e 589 as well as in the tracing at m/e 586 
corresponding to a considerable formation of 
25-hydroxyvitamin Da. The amount of unlabelled 
25-hydroxyvitamin Da could be calculated from the 
ratio between the peak height at m/e 586 and at 
m/e 589, with use of a standard curve [3]. The 
specific rate of formation of 25-hydroxyvitamin Ds 
obtained in 5 different experiments varied from 
0.01-0.02 nmol.nmol cytochrome P-450-l .min-’ 
(cf. table 1). In tig.2B, MID-recordings at m/e 586 and 
m/e 589 are also shown of the derivative of a purified 
extract of an incubation of vitamin Da with the 
incubation mixture minus ferredoxin. Only very 
small peaks were obtained in the tracing at m/e 586, 
corresponding to a very low formation of unlabelled 
25-hydroxyvitamin Da (cf. table 1). The small forma- 
tion of 25-hydroxyvitamin Ds seen when ferredoxin 
reductase was excluded from the incubation mixture 
(table 1) can be explained by the presence of a small 
amount of this reductase in the cytochrome P-450 
preparation [8,9]. A mass spectrum of the material 
analyzed in fig.2A showed that it consisted of a 
mixture of unlabelled and *Hs labelled derivative of 
25-hydroxyvitamin Da (cf. table 1). The identity of 
25-hydroxyvitamin Da was further confirmed by com- 
bined GC-MS of purified material obtained from 
3 separate incubations to which no *H,-labelled 
25-hydroxyvitamin Da had been added. As shown in fig.3 
prominent peaks were observed at m/e 586 (M), 439 
(M-90-57) and m/e 13 1 (cleavage between C-24 and 
C-25 [3]). The same peaks with the same relative 
intensity were observed in the mass spectrum of the 
derivative of authentic 25-hydroxyvitamin Ds (fig.3). 
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Fig.1. HPLC on Spherisorb silica after pre-purification on Spherisorb ODS of the methanol/chloroform extract of incubations 
containing the soluble liver mitochondrial cytochromeP-450 and with vitamin D, as substrate. The incubation conditions 
as well as extraction and chromatography were as given in section 2. (No *H,-labelled 25-hydroxyvitamin D, was added to the 
extract.) (A) Authentic 25-hydroxyvitamin D, (43 ng); (B) complete incubation system; (C) incubation system without 
ferredoxin added. 
Table 1 
25-Hydroxytation of vitamin Ds by soluble rat liver mitochondrial cytochrome P-450 
Components present in 
the incubation medium 
Rat Liver mitochondrial 
cytochrome P-450 (nmol) 
Bovine adrenal 
ferredoxin reductasc (pmol) 
Bovine adrenal 
fcrredoxin (nmol) 
Formation of 25-hydroxy- 
vitamin D, (ng) (mean f SD, n = 5) 
0.74 0.14 0.74 
26 26 
- 5.5 5.5 
5r4 30 235r64 
For incubation conditions see section 2 
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Fig.2. MID recordings at m/e 586 and m/e 589 of the trimethylsilyl/t-butyldimethylsilyl derivative of incubation extract of 
vitamin D, with the complete reconstituted system (A) and reconstituted system minus ferredoxin (B). A fiied amount of 
*H,-labelled 25llydroxyvitamin D, (145 ng) had been added to the incubation mixture prior to extract (cf. section 2). 
4. Djscu~ion 
This work clearly demonstrates that liver 
mitochondria contain a cytochrome P-450 with the 
ability to catalyze 2Shydroxylation of vitamin I&. 
This enzyme activity was absolutely dependent upon 
both ferredoxin and ferredoxin reductase. The latter 
finding excludes that the cytochrome P-450 is of 
microsomal origin f6f. The rate of conversion obtained 
with the reconstituted system was of the same order 
of magnitude as that obtained with intact 
mitochondrial fraction [3]. It should be noted, how- 
ever, that the in vitro conditions of the present 
system may not be optimal and it can not be excluded 
that the transfer of vitamin D3 through the 
mitochondri~ membranes may be rate-l~it~g when 
using intact mitochondria (cf. [S]). 
The cytochrome P-450 preparation used in the 
present experiments has been shown to catalyze 25 
and 26.hydroxylation of cholesterol 16,121 and 
26-hydroxylation of a number of (&-steroids, lnter- 
mediates in the formation of bile acids [S]. Whether 
the same or a different species of cytochrome P-450 
is responsible for the 25-hy~oxylation of vitamin 4 
can not yet be decided. With intact mitochondria, it
was shown that the vitamin Ds 2Shydroxylase had 
certain characteristics different from the cholesterol 
25- and 26.hydroxylase [3]. Thus exogenous NADPH 
was found to stimulate 25-hydroxylation of vitamin 
& to a higher extent than reported for 25- and 
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Fig.3. Mass spectrum of the pyro-form of the trimethylsilyllt- 
butyldimethylsilyl derivative of authentic 25hydroxyvitamin 
D, (upper spectrum) and 2S-hydroxyvitamin D, isolated 
from incubations of vitamin D, with the reconstituted 
system (Iower spectrum). AII peaks with an intensity <2.5% 
of that of the base peak at m/e 131 were deleted. 
26-hydroxylation of cholesterol [ 131. Furthermore, 
in contrast to 25. and 26-hydroxylation of 
cholestero1, Mg2’ had little or no stimulatory effect 
on 25-hydroxylation of vitamin Ds [3]. It was shown, 
however, that under the conditions used in [3], there 
is some permeability of the mitochondria towards 
NADH (LB., I.H., unpubli~ed). If non-permeable 
mitochondria are used, the properties of the mito- 
chondrial 25hydroxylase active on vitamin Da are 
more similar to the properties of the enzyme system 
catalyzing 25- and 26-hydroxylation of cholesterol. 
Inhibition studies with the reconstituted system may 
give further information concerning a possible 
heterogeneity of the present mitochondrial 
cytochrome P-450 fraction, and such studies are in 
progress. 
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